Artificial Tears Regimen for Dry Eye Disease
For patients using artificial tears more than 4 times daily, preservative-free formulations are required; when used with cyclosporine (Restasis), maintain a 15-minute interval between products, and contact lenses must be removed before instillation with a 15-minute wait before reinsertion. 1, 2
Dosing Frequency Based on Disease Severity
Mild Dry Eye
- Preserved artificial tears are acceptable if used ≤4 times daily 1, 3
- Patients with healthy ocular surfaces can tolerate preservatives at this frequency
- Once frequency exceeds 4 times daily, switch to preservative-free formulations 1
Moderate to Severe Dry Eye
- Preservative-free artificial tears exclusively 1, 3
- Use as frequently as needed throughout the day
- Required for patients with:
- Poor ocular surface condition
- Severe corneal epithelial defects
- Superficial punctate keratopathy (SPK)
- Any chronic, frequent use pattern 3
Timing with Cyclosporine (Restasis)
The FDA label provides explicit guidance on concomitant use:
- Allow 15 minutes between Restasis and artificial tears 2
- This interval applies whether artificial tears are used before or after cyclosporine
- Restasis itself is dosed twice daily, approximately 12 hours apart 2
- Research supports that the choice of artificial tear used with cyclosporine significantly affects outcomes, with some formulations showing better compatibility 4
Practical Sequencing
One approach based on the evidence: Apply cyclosporine first, wait 15 minutes, then use artificial tears. This allows the anti-inflammatory medication to establish contact with the ocular surface before lubrication. However, the reverse sequence is equally valid per FDA guidance 2.
Contact Lens Considerations
Contact lenses must be removed before instilling any eye drops, with a mandatory 15-minute wait before reinsertion 2. This is critical because:
- Restasis specifically states patients should not wear contact lenses during administration 2
- The 15-minute interval allows the medication/tear substitute to clear from the ocular surface
- Patients with decreased tear production (the target population for these treatments) typically should not wear contact lenses at all 2
For Contact Lens Wearers Who Continue Wearing Lenses
If contact lens wear continues despite dry eye:
- Remove lenses before any drop instillation
- Wait 15 minutes after drops before reinserting lenses 2
- Consider using cyclosporine 10 minutes before inserting lenses or after removing them 5
- Preservative-free formulations are mandatory to avoid preservative accumulation in lens material 6
- Research shows cyclosporine can improve contact lens tolerance when used appropriately 7
Critical Formulation Considerations
Preservative toxicity is dose-dependent and cumulative:
- Preservatives (especially benzalkonium chloride) cause damage to meibomian glands, conjunctival epithelium, and corneal epithelium 8
- The 4-times-daily threshold exists because preservative-related toxicity becomes clinically significant beyond this frequency 1, 3
- Preserved formulations show uniform bactericidal activity but at the cost of ocular surface toxicity 9
- Preservative-free formulations carry higher contamination risk but are essential for ocular surface health in frequent users 9, 8
Common Pitfalls to Avoid
- Using preserved tears frequently: This worsens the underlying dry eye through preservative toxicity 8
- Ignoring the 15-minute interval: Reduces efficacy of both cyclosporine and artificial tears 2
- Instilling drops with contact lenses in place: Causes medication/preservative accumulation in lens material and reduces drug efficacy 2, 6
- Assuming all artificial tears are equivalent: Formulation matters significantly, especially when used with cyclosporine 4
Additional Practical Points
- Thicker formulations (gels, ointments) last longer but blur vision more 1
- Single-dose vials eliminate preservative exposure entirely but may support more microbial growth if contaminated 9
- For overnight use, consider ointments or moisture chamber devices 3
- Lipid-containing supplements should be considered if meibomian gland dysfunction is present 3